Bayesian integration of longitudinal and survival outcomes in Alzheimer's disease prediction
Alzheimer's & Dementia · 2025
DOI: 10.1002/alz.70094 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Haotian Zou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics & Bioinformatics, Duke University, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, National Institute on Aging.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Accurate prediction of Alzheimer's disease (AD) dementia onset and progression to mild cognitive impairment (MCI) is crucial for early intervention and clinical trial design. This study presents a predictive framework leveraging Bayesian model averaging (BMA) with a multivariate functional mixed model (MFMM) to integrate multivariate longitudinal outcomes and survival data. METHODS The training cohort included 1012 participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI). The validation cohort comprised 2087 participants from the National Alzheimer's Coordinating Center (NACC). BMA methods, including stacking and pseudo‐BMA+, aggregated predictions across candidate models to enhance accuracy and robustness. Predictive performance was evaluated using the C‐index, a measure of discrimination. RESULTS Compared to the composite model, BMA improved prediction accuracy. The C‐index was 0.777 (stacking) and 0.771 (pseudo‐BMA+) in ADNI and 0.743 and 0.738 in NACC. DISCUSSION This framework offers a robust tool for personalized medicine, enabling accurate predictions and enhanced generalizability across diverse populations. Highlights We introduced a novel joint modeling framework integrating multivariate longitudinal outcomes (Mini‐Mental State Examination and Clinical Dementia Rating Sum of Boxes) with survival data to predict Alzheimer's disease dementia onset and progression. We validated the framework across complementary datasets: Alzheimer's Disease Neuroimaging Initiative (training) and National Alzheimer's Coordinating Center (NACC; validation), with NACC providing a demographically diverse population to assess generalizability. The model enhanced predictive accuracy using Bayesian model averaging, which synthesizes insights across multiple models to reduce uncertainty and improve robustness. The model demonstrated consistent and clinically relevant performance, supporting its applicability for early intervention, precision medicine, and clinical trial design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biostatistics & Bioinformatics, Duke University, Durham, North Carolina, USA.
- Department of Neurology, Duke University School of Medicine, Durham, North Carolina, USA.
- Department of Psychiatry & Behavioral Sciences, Duke University, Durham, North Carolina, USA.
- Department of Psychiatry & Behavioral Sciences, Duke Clinical Research Institute (DCRI), Durham, North Carolina, USA.
ORCID-Profile: Haotian Zou, Sheng Luo
Förderung
- NIA NIH HHS
- National Institute on Aging
Zitieren
APA
Zou, H., Lutz, M. W., Welsh-Bohmer, K., & Luo, S. (2025). Bayesian integration of longitudinal and survival outcomes in Alzheimer's disease prediction. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70094
Vancouver
Zou H, Lutz MW, Welsh-Bohmer K, Luo S. Bayesian integration of longitudinal and survival outcomes in Alzheimer's disease prediction. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70094
BibTeX
@article{Zou2025,
author = {Zou, Haotian and Lutz, Michael W and Welsh-Bohmer, Kathleen and Luo, Sheng},
title = {Bayesian integration of longitudinal and survival outcomes in Alzheimer's disease prediction},
journal = {Alzheimer's & Dementia},
year = {2025},
doi = {10.1002/alz.70094}
}
EUVIMED